A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity and had antitumor activity in patients with malignant pleural disease from mesothelioma, according to new results.
from Latest Science News -- ScienceDaily https://ift.tt/2UowGYe
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment